athenahealth (ATHN) PT Raised to $152 at UBS Following 13D Filing by Elliott Associates on 5/18; 'Pricing in Potential Upside from Operational Improvements'

May 30, 2017 10:04 AM EDT Send to a Friend
UBS raised its price target on athenahealth (NASDAQ: ATHN) to $152.00 (from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login